Corrigendum to "Once-daily upadacitinib versus placebo in adults with extensive non-segmental vitiligo: a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-ranging study" [eClinicalMedicine 73(2024) 102655].
Where this comes from
- Record sourced from PubMed, PMID 40191147.
- Also identified by DOI 10.1016/j.eclinm.2025.103167 and PMC identifier 11968280.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
[This corrects the article DOI: 10.1016/j.eclinm.2024.102655.].